TRIM32 has been implicated in carcinogenesis, with elevated levels of TRIM32 has been associated with the development of cancer, as increased levels of TRIM32 mRNA have been found in hepatocellular carcinoma, GC, and breast cancer, where it serves as a biomarker for prognosis [10–12]. Here, TRIM32 is linked to hepatocellular carcinoma.